Fig. 1From: Dynamic and specific immune responses against multiple tumor antigens were elicited in patients with hepatocellular carcinoma after cell-based immunotherapyThe schematic diagram of one course of MASCT treatment (a), the manufacturing process of mature DCs (b), and the activated T cells (c)Back to article page